搜索此博客

2019年7月7日星期日

Lusutrombopag, CAS 1110766-97-6 Sole GMP Manufacturer

Lusutrombopag, CAS 1110766-97-6  Sole GMP Manufacturer

Lusutrombopag, CAS 1110766-97-6  stable novel crystalline or amorphous form both we have, Lusutrombopag, CAS 1110766-97-6 no any IP problem. Lusutrombopag, CAS 1110766-97-6  DMF filling, free sample of Lusutrombopag, CAS 1110766-97-6 .

EOS Med Chem have already carried out Lusutrombopag, CAS 1110766-97-6  batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lusutrombopag, CAS 1110766-97-6  , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Lusutrombopag, CAS 1110766-97-6  Intermeidates list, most from GMP plant:
Lusutrombopag, CAS 1110766-97-6 Intermediate 267651-23-0, stock 7.3kg, assay 98.9%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 952103-45-6, stock 8.4kg, assay 98.4%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 638-45-9, stock 4.6kg, assay 98.8%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 1110767-94-6, stock 6.1kg, assay 98.6%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 67442-07-3, stock 8.4kg, assay 98.3%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 1110767-96-8, stock 8.1kg, assay 98%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 17356-08-0, stock 6.3kg, assay 98.4%, White powder.
Lusutrombopag, CAS 1110766-97-6 Intermediate 3699-66-9, stock 9.2kg, assay 98.3%, White powder.
Lusutrombopag, Intermediate  1110766-97-6, stock 2.8kg, assay 98.9%, White powder.
Lusutrombopag, Intermediate  1110767-89-9, stock 8kg, assay 98.8%, White powder.
Lusutrombopag, Intermediate  1110767-98-0, stock 4.3kg, assay 98.6%, White powder.
Lusutrombopag, Intermediate  153203-80-6, stock 9.1kg, assay 98.5%, White powder.

Lusutrombopag, CAS 1110766-97-6  HNMR, MASS, COA, MSDS we have.

Lusutrombopag, CAS 1110766-97-6 , free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com